<DOC>
	<DOCNO>NCT00620815</DOCNO>
	<brief_summary>Evaluate immune response reactogenicity H5N1 vaccination adult age 18 year ( part tetravalent vaccine )</brief_summary>
	<brief_title>Safety Immunogenicity Two Doses Tetravalent Influenza Vaccine Adults Aged 18 Years Above</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>MF59 oil emulsion</mesh_term>
	<criteria>Healthy subject ( age 18 year ) sign informed consent form Any acute chronic illness Receipt seasonal influenza vaccine current season 2007/2008 Known suspect impairment/alteration immune function Receipt another vaccine within 3 week prior Visit 1 plan vaccination within 3 week follow last study vaccination Any serious disease Hypersensitivity egg , chicken protein , chicken feather , influenza viral protein , neomycin kanamycin component study vaccine Receipt blood , blood product immunoglobulins 3 month prior vaccination</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>avian flu</keyword>
	<keyword>seasonal influenza vaccine</keyword>
	<keyword>influenza vaccine</keyword>
	<keyword>prepandemic vaccine</keyword>
	<keyword>virus strain potential cause pandemic</keyword>
	<keyword>tetravalent vaccine</keyword>
	<keyword>Prophylaxis influenza</keyword>
</DOC>